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ABSTRACT
Gene expression profiling of cancer tissues is
expectedtocontributetoourunderstandingofcancer
biology as well as developments of new methods of
diagnosis and therapy. Our collaborative efforts in
Japanhavebeenmainlyfocusedonsolidtumorssuch
as breast, colorectal and hepatocellular cancers. The
expression data are obtained by a high-throughput
RT–PCR technique, and patients are recruited mainly
from a single hospital. In the cancer gene expression
database(CGED),theexpressionandclinicaldataare
presented in a way useful for scientists interested in
specificgenesorbiologicalfunctions.Thedatacanbe
retrieved either by gene identifiers or by functional
categories defined by Gene Ontology terms or
the Swiss-Prot annotation. Expression patterns of
multiplegenes,selectedbynamesorsimilaritysearch
ofthepatterns,canbecompared.Visualpresentation
of the data with sorting function enables users to
easily recognize of relationships between gene
expression and clinical parameters. Data for other
cancers such as lung and thyroid cancers will be
added in the near future. The URL of CGED is http://
cged.hgc.jp.
INTRODUCTION
Gene expression proﬁling of human cancer tissues is an emer-
ging approach based on genomics, whose main focus is the
characterization of differences among cancer tissues from
individual patients (1,2). The results are intended to be applied
to therapeutics, especially for diagnosis, based on heterogen-
eity in gene expression among tumor tissues of individual
patients.
We developed the cancer gene expression database (CGED)
to present gene expression data and clinical information on
human cancer tissues. The data in CGED were obtained
through collaborative efforts of Nara Institute of Science
and Technology and Osaka University School of Medicine
to identify genes of clinical importance. Although the main
objective of the project is to identify genes for diagnosis or
potential therapeutic targets, the database provides a rich
source of information for basic research.
The data in this database are quite unique both in analytical
and clinical aspects. First, all the data were obtained using
adaptor-tagged competitive PCR (ATAC-PCR) (3,4), an
advanced version of quantitative RT–PCR. Generally, RT–
PCR produces data of better quality than those based on
hybridization-based techniques (5). Second, tissue samples
were obtained mainly from a single hospital. This eliminates
deterioration of clinical data by a difference in medical prac-
tice, commonly found in data collected from multiple hospi-
tals. In addition, the racial background is the same, because all
the patients are oriental. This feature also eliminates potential
effects of a racial background on gene expression. The high
quality of the expression and clinical data is demonstrated by
the successful identiﬁcation of prognostic genes in breast (6),
colorectal (7) and hepatocellular cancers (8).
In CGED, considering the characteristics of database sys-
tems, we present expression and clinical data in a way useful
for individual scientists interested in speciﬁc subjects of
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doi:10.1093/nar/gki117cancer molecular biology. CGED enables experimental scient-
ists to access the information of interest, without handling
expression data matrices.
GENERAL FEATURES OF GENE EXPRESSION DATA
AND CLINICAL INFORMATION
Most tissue samples were obtained from patients in the Osaka
University Medical School Hospital or the Osaka Medical
Center for Cancer and Cardiovascular Diseases. The studies
were approved by the Institutional Review Board, Osaka Uni-
versity Medical School or the Osaka Medical Center, and
written informed consent was obtained from each patient.
The ﬂow chart of the data production is summarized in
Figure 1. We at ﬁrst made 30 directed cDNA libraries using
mRNA puriﬁed from target cancer tissues, and performed EST
sequencing. Inserts of the libraries were 30 end cDNA frag-
ments generated by MboI digestion (9). The number of reads
varied from 4000 to 20000. Then, we selected genes for assay
by descending order of abundance. In addition, we selected
genes related to each cancer by a literature survey, and sub-
jected them for ATAC-PCR assay. These processes guaran-
teed that all assayed genes were expressed in the target cancer
tissue. Gene expression data by ATAC-PCR were obtained as
relative expression levels against control samples. We usually
used mixtures of tumor tissues from several patients as con-
trols to detect any slight differences among tumor tissues from
different patients. All the data were logarithmically converted
after normalization by the median of samples, and then by that
of genes. So far the following projects have been ﬁnished, and
data deposited in CGED.
Breast cancer. Analyzed samples: 98 primary breast tumor
tissues and 10 normal breast tissues; number of genes ana-
lyzed, 2412. Breast cancer has several molecular markers
correlating with malignancy, including estrogen and proges-
terone receptors, erbB2 and p53. These markers are also
included in clinical parameters.
Colorectal cancer. Analyzed samples: 100 colorectal can-
cer tissues and 11 normal colon tissues; number of genes
analyzed, 1536.
Hepatocellular cancer. Analyzed samples: 120 hepatocel-
lular cancer tissues, 86 non-tumor (adjacent to tumor) tissues
and 32 normal liver tissues; number of genes analyzed, 3072.
The main etiological factor of hepatocellular cancer is virus
infection, i.e. hepatitis B virus (HBV) and hepatitis C virus
(HCV). Records of infection with these viruses are included in
clinical parameters. Because of the limitation of samples dis-
played by mosaic plots, we randomly selected 100 samples for
CGED.
Esophageal cancer. Analyzed samples: 160 esophageal
cancer tissues; number of genes analyzed, 1904. Clinical
records include stage classiﬁcation, depth of invasion, number
of metastatic lymph nodes.
DESCRIPTION OF THE DATABASE
The objective of this database is not to provide full access to
our data matrices (the entire data matrix can be downloaded
from http://genome.mc.pref.osaka.jp/CGIP.html), but to pre-
sent information useful for scientists interested in speciﬁc
genes and biological functions. Those interested in identifying
diagnostic or target genes should instead use entire data
matrices. The structure of web pages in CGED is shown in
Figure 2. Pages are marked by Roman numbers, which are
referred to in the following description of CGED.
QUERY
The top page (I in Figure 2) of CGED has two types of data
retrieval systems. One is a conventional data retrieval system
based on gene names and gene identiﬁers such as GenBank
accession number. In addition, data of a group of genes can be
retrieved using Gene Ontology (GO) terms (10) or words in
functional annotation of Swiss-Prot (11). The latter function
enables users to select a group of genes belonging to a speciﬁc
functional category. For example, when ‘oncogene’ is entered
as a keyword, a list of genes in the CGED, categorized as
oncogene-related, either by GO or the Swiss-Prot functional
annotation, is displayed on the search result page (II in
Figure 2). Each gene has a link to its information page (V
in Figure 2) including various identiﬁcation numbers such as
RefSeq, GenBank, UniGene and LocusLink with links to these
websites. It also includes GO terms and functional annotation
of the Swiss-Prot. Expression patterns of genes can be dis-
played in two ways: comparison of expression patterns of
selected genes and expression pattern similarity search.
COMPARISON OF EXPRESSION PATTERNS
Genes and a cancer type should be selected from check boxes
and from the menu on the right-hand side of the search result
page (II), respectively. After clicking the display button in
‘selected genes’ in the menu on the right, gene expression
patterns are displayed as a mosaic plot, which is a popular
presentation method of microarray data (Gene Expression and
Clinical Data Display, III in Figure 2) (12). This page is
accompanied by a list of displayed genes in another window
Figure 1. Outline of the gene expression data production. Genes for assays
wereselectedfromapoolofgenesappearingintheESTcollection(theleftpart
ofthefigure).Thedataproductionpipelinefromtissuestothedatabaseisshown
in the right part.
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(V). This list also provides information on transcript abun-
dance by EST frequencies in all of our cDNA libraries and in
the library of the selected cancer.
GENE EXPRESSION PATTERN SIMILARITY SEARCH
At ﬁrst, a gene of interest and a cancer type are selected by
clicking a radio button and from the menu on the right of the
Figure3.Colordisplayofthegeneexpressionpatternsandclinicalinformation.Clinicalinformation(toppartofthegraph)andgeneexpressiondata(bottompartof
thegraph)of98breastcancertissuesand10normaltissuesarerepresentedbysmallcolorboxes.Alegendofcolorboxesforclinicalinformationisattachedtoeach
graph (not shown in this figure). Gene expression levels are schematically represented by a color gradient from light red to light green: light red, high level of gene
expression; black, middle level; light green, low level. The details of gene names are shown in another window (not shown in this figure). Figures next to symbol
names represent transcript abundance by EST frequencies in all of our cDNA libraries (left) and in the library of the selected cancer (right). The graph is a result of
searching for genes whose expression patterns are similar to that of zinc-alpha2-glycoprotein (the top gene numbered 0) and the following sort by its expression
levels. Zinc-alpha2-glycoprotein is one of the prognostic genes of breast cancer (6), and its expression level is correlated with estrogen receptor (ER).
Figure2.OutlineofCGED.WebpagesconstitutingCGEDaremarkedbyRomannumbers.Inthetoppage(I),thedatabaseiseithersearchedbygeneidentifiersorby
keywords.Fromthesearchresultpage(II),expressionpatternsofmultiplegenesaredisplayedandcompared.Fromthesamepage,byselectingasinglegene,genes
withasimilarexpressionpatternaresearchedanddisplayed(III).PageIIIisaccompaniedbyagenenamelist(IV).EachgenelistedinpagesIIandIVhasalinktoits
information page (V).
Nucleic Acids Research, 2005, Vol. 33, Database issue D535search result page (II). Then, by clicking the display button in
‘similarity search’, CGED displays a predeﬁned number of
genes by the order of similarity of expression pattern (III).
Currently, Euclidean distance is used as the measure of simi-
larity. The page displaying gene expression patterns (III) is
also accompanied by a list of displayed genes (IV).
SORTING BY GENE EXPRESSION OR CLINICAL
PARAMETERS
The results of multiple gene display and the similarity search
(III) can be sorted. The samples can be sorted either by the
order of gene expression of a selected gene or by clinical
parameters such as the presence and absence of metastasis.
Sorting is useful for easy recognition of relationships between
gene expression and clinical parameters. An example is shown
in Figure 3.
COMMENTS AND FUTURE PLANS
Gene expression data matrices of human cancers are usually
distributed as ﬂat ﬁles. However, it is not an easy task for
experimental biologists to analyze the large data matrix by
themselves. The aim of the CGED is to bypass the need of
analyzing the complex data matrix, and to enable direct access
to the information the individual scientist is interested in.
Data analysis of glioblastoma and thyroid cancers is in
progress. In addition, expression data acquisition of lung can-
cer will be ﬁnished within the ﬁscal year 2004. These data will
be deposited in CGED after approval by the local committee
consisting of participants of the project. Some of the patients
recruited forthese studies are beingclinicallyfollowed up, and
the clinical information will be regularly updated.
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